Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Valneva SE changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 11 | 11 | 0 |
| Shares | 414.0K | 378.3K | −35.7K (−8.6%) |
| Value | $4.27M | $5.55M | +$1.28M (+30.0%) |
New holders (3)
Institutions that held Valneva SE at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ridgewood Investments LLC | 550 | $8.11K | 0.00% |
| UBS Group AG | 2 | $30 | 0.00% |
| Ronald Blue Trust, Inc. | 6 | $0 | 0.00% |
Sold out (3)
Institutions that held Valneva SE at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Bank of America Corp | 25,000 | $256.3K |
| Bank of Montreal | 10,538 | $163.3K |
| Savior LLC | 5 | $51 |